Culture Biosciences - About the company
Culture Biosciences is a series C company based in San Francisco (United States), founded in 2016 by Will Patrick. It operates as a Provider of biomanufacturing hardware and software tools for research purposes. Culture Biosciences has raised $107M in funding from investors like Y Combinator, Cultivian Sandbox and S32, with a current valuation of $*****. The company has 36 active competitors, including 5 funded and 2 that have exited. Its top competitors include companies like PBS Biotech, Bionet Engineering and MicroBiopharm Japan.
Company Details
Provider of biomanufacturing hardware and software tools for research purposes. They have developed the digital biomanufacturing platform by integrating automated bioreactors, robotic sample handling, and cloud data monitoring. It offers services such as strain screening, media optimization, and process development.
- Website
- www.culturebiosciences.com/
- Email ID
- *****@culturebiosciences.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2016
Location
San Francisco, United States
Stage
Series C
Total Funding
$107M in 6 rounds
Latest Funding Round
Post Money Valuation
$***** as on Oct 14, 2021
Investors
Ranked
1st among 36 active competitors
Employee Count
61 as on Aug 31, 2026
Similar Companies
Legal entities associated with Culture Biosciences
Culture Biosciences is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
CULTURE BIOSCIENCES, INC. CIN: 813761972 , United States, Active | Aug 24, 2016 | - | 86 (As on Dec 31, 2023) | - |
Sign up to download Culture Biosciences' company profile
Culture Biosciences's funding and investors
Culture Biosciences has raised a total funding of $107M over 6 rounds. Its first funding round was on 2018. Its latest funding round was a Series C round on Dec 16, 2025 for $*****. 4 investors participated in its latest round. Culture Biosciences has 24 institutional investors.
Here is the list of recent funding rounds of Culture Biosciences:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 16, 2025 | 9431874 | Series C | 7673845 | 3519205 | 6782440 | 7309031 |
Oct 14, 2021 | 7605391 | Series B | 1657764 | 6610828 | 9198235 | |
Mar 04, 2020 | 9453602 | Series A | 5918476 | 7443550 |
View details of Culture Biosciences's funding rounds and investors
Culture Biosciences' founders and board of directors
Founder? Claim ProfileThe founders of Culture Biosciences is Will Patrick. Chris Williams is the CEO of Culture Biosciences.
Here are the details of Culture Biosciences' key team members:
- Will Patrick: Former Co-Founder & CEO of Culture Biosciences. Contact Info: 1 email address
- Chris Williams: CEO of Culture Biosciences. Contact Info: 1 email address
Culture Biosciences' Board of Directors
Culture Biosciences's board has 2 active members. William Graham Patrick and Matthew Adams Ball are independent board members.Here is the list of Culture Biosciences' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Independent board member | - | Current | 6y 6m | |
ohsgqyl | Independent board member | - | Current | 9y 5m |
View details of Culture Biosciences's Founder profiles and Board Members
Culture Biosciences' employee count trend
Culture Biosciences has 61 employees as of Aug 26. Here is Culture Biosciences's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Culture Biosciences's Competitors and alternates
Top competitors of Culture Biosciences include PBS Biotech, Bionet Engineering and MicroBiopharm Japan. Here is the list of Top 10 competitors of Culture Biosciences, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Culture Biosciences 2016, San Francisco (United States), Series C | Provider of biomanufacturing hardware and software tools for research purposes | $107M | 69/100 | |
2nd | PBS Biotech 2006, Camarillo (United States), Series B | Developer of single-use bioreactors for the production of vaccines, therapeutic proteins, and cell therapies | $70.2M | 56/100 | |
3rd | Bionet Engineering 1999, Santiago Papasquiaro (Mexico), Unfunded | Provider of products and services for bioprocess engineering | - | - | 48/100 |
4th | MicroBiopharm Japan 2011, Tokyo (Japan), Acquired | Provides discovery and contract research services to the biopharma companies | $124K | 47/100 | |
5th | Developer of single-use bioreactors for cell and gene therapies | $280K | 40/100 | ||
6th | Bioreactors for screening and bioprocess development | - | 38/100 | ||
7th | Provider of lab equipment for bacterial transformations and culture growth | $250K | 35/100 | ||
8th | Innovel Intelligent Technology 2018, Suzhou (China), Series A | Provider of bioreactors for cell culture | $15.3M | - | 34/100 |
9th | CARR Biosystems 1993, Clearwater (United States), Funding Raised | Developer of bioprocessing solutions for biotech industries | - | 30/100 | |
10th | Distek 1976, North Brunswick (United States), Unfunded | Pharmaceutical and bioprocessing lab instruments and qualification services provider | - | - | 29/100 |
Looking for more details on Culture Biosciences's competitors? Click here to see the top ones
Culture Biosciences's Investments and acquisitions
Culture Biosciences has made no investments or acquisitions yet.
Reports related to Culture Biosciences
Here is the latest report on Culture Biosciences's sector:
News related to Culture Biosciences
Media has covered Culture Biosciences for a total of 3 events in the last 1 year, 1 of them has been about partnerships and 1 about people movement.
•
•
Culture Biosciences Closes Series C Round to Expand Stratyx 250 and Console PlatformGlobeNewswire•Dec 16, 2025•Culture Biosciences, Cultivian Sandbox, Synthesis Capital, Northpond Ventures and 1 other
•
•
•
•
Welcoming Victor Bornsztejn as Senior Vice President of CommercialGlobeNewswire•Jan 21, 2025•Culture Biosciences
•
Culture Biosciences Appoints Chris Williams as Chief Executive OfficerGlobeNewswire•Sep 26, 2024•Culture Biosciences
•
•
Culture Biosciences Appoints Darcy Birse as Chief Commercial OfficerGlobeNewswire•Sep 13, 2023•Culture Biosciences
•
Biotech Executive Beth Thompson-Webb Joins Culture Biosciences’ Board of DirectorsGlobeNewswire•Jul 13, 2023•Culture Biosciences, Virica Biotech
Are you a Founder ?
FAQs about Culture Biosciences
Explore our recently published companies
- Way - Helsinki based, 2024 founded, Seed company
- Delite - Hyderabad based, 2010 founded, Unfunded company
- Yuki - Tel Aviv based, 2023 founded, Seed company
- Hedgepointcapital.com - 2021 founded, Funding Raised company
- MicroRoboTech - Hangzhou based, 2025 founded, Series A company
- Semper Plugins - Durham based, 2011 founded, Acquired company